Pasithea Therapeutics KTTA Q4 2026 earnings
Reported February 25, 2026
EPS-$0.18In line
Revenue estimate$200.0K
EPS estimate-$0.18
Next report
Date not yet announcedVersus estimates
Diluted EPS
Ask the moment Pasithea Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Pasithea Therapeutics report Q4 2026 earnings?
- Pasithea Therapeutics (KTTA) reported Q4 2026 earnings on February 25, 2026.
- What were Pasithea Therapeutics's Q4 2026 revenue and EPS?
- Pasithea Therapeutics reported eps of $-0.18 for Q4 2026.
- Did Pasithea Therapeutics beat estimates in Q4 2026?
- EPS beat the consensus estimate of $-0.18 by $0.00.
- How did Pasithea Therapeutics's Q4 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 79.8% from $-0.89.